CN109310670B - 氨基甲酸酯化合物用于预防性治疗头痛的用途 - Google Patents

氨基甲酸酯化合物用于预防性治疗头痛的用途 Download PDF

Info

Publication number
CN109310670B
CN109310670B CN201780030914.4A CN201780030914A CN109310670B CN 109310670 B CN109310670 B CN 109310670B CN 201780030914 A CN201780030914 A CN 201780030914A CN 109310670 B CN109310670 B CN 109310670B
Authority
CN
China
Prior art keywords
migraine
headache
formula
use according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201780030914.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN109310670A (zh
Inventor
申蕙园
朴伦卿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SK Biopharmaceuticals Co Ltd
Original Assignee
SK Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SK Biopharmaceuticals Co Ltd filed Critical SK Biopharmaceuticals Co Ltd
Publication of CN109310670A publication Critical patent/CN109310670A/zh
Application granted granted Critical
Publication of CN109310670B publication Critical patent/CN109310670B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201780030914.4A 2016-05-19 2017-05-18 氨基甲酸酯化合物用于预防性治疗头痛的用途 Active CN109310670B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20160061374 2016-05-19
KR10-2016-0061374 2016-05-19
PCT/KR2017/005171 WO2017200316A1 (ko) 2016-05-19 2017-05-18 두통의 예방학적 치료를 위한 카바메이트 화합물의 용도

Publications (2)

Publication Number Publication Date
CN109310670A CN109310670A (zh) 2019-02-05
CN109310670B true CN109310670B (zh) 2022-03-29

Family

ID=60325338

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780030914.4A Active CN109310670B (zh) 2016-05-19 2017-05-18 氨基甲酸酯化合物用于预防性治疗头痛的用途

Country Status (8)

Country Link
US (2) US10456376B2 (enExample)
EP (1) EP3459541B1 (enExample)
JP (1) JP6986521B2 (enExample)
KR (1) KR102421006B1 (enExample)
CN (1) CN109310670B (enExample)
CA (1) CA3024278A1 (enExample)
ES (1) ES2893456T3 (enExample)
WO (1) WO2017200316A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11406620B2 (en) * 2017-11-14 2022-08-09 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current
ES2978226T3 (es) * 2018-09-21 2024-09-09 Sk Biopharmaceuticals Co Ltd Compuesto de carbamato y uso de la formulación que lo comprende para prevenir, aliviar o tratar el trastorno de estrés agudo o el trastorno de estrés postraumático
CA3113052A1 (en) * 2018-09-21 2020-03-26 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for prevention, alleviation, or treatment of status epilepticus
IL293096A (en) * 2019-11-22 2022-07-01 Sk Biopharmaceuticals Co Ltd Oral pharmaceutical composition comprising carbamate compound and preparation method therefor

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349556A (en) * 1976-06-24 1982-09-14 Bayer Aktiengesellschaft Pesticidally active 1-acyloxy-1-phenyl-2-azolyl-ethanes
CN1620425A (zh) * 2001-12-21 2005-05-25 奥索-麦克尼尔药品公司 制备氨基甲酸2－(取代苯基)－2－羟基－乙酯的方法
CN101056629A (zh) * 2004-09-16 2007-10-17 詹森药业有限公司 2－苯基－1,2－乙二醇－(二)氨基甲酸酯治疗癫痫发生和癫痫的用途
CN101228138A (zh) * 2005-04-22 2008-07-23 Sk株式会社 神经治疗吡咯化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
DE2628420A1 (de) * 1976-06-24 1978-01-05 Bayer Ag 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide
US8501436B2 (en) 2009-06-22 2013-08-06 Sk Biopharmaceuticals Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
US8404461B2 (en) 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
CN102574344B (zh) 2009-10-16 2016-03-02 诺华股份有限公司 用于运输接触透镜通过浸浴的设备及方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349556A (en) * 1976-06-24 1982-09-14 Bayer Aktiengesellschaft Pesticidally active 1-acyloxy-1-phenyl-2-azolyl-ethanes
CN1620425A (zh) * 2001-12-21 2005-05-25 奥索-麦克尼尔药品公司 制备氨基甲酸2－(取代苯基)－2－羟基－乙酯的方法
CN101056629A (zh) * 2004-09-16 2007-10-17 詹森药业有限公司 2－苯基－1,2－乙二醇－(二)氨基甲酸酯治疗癫痫发生和癫痫的用途
CN101228138A (zh) * 2005-04-22 2008-07-23 Sk株式会社 神经治疗吡咯化合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
头痛的国际分类;中岛健二;《日本医学介绍》;20070106(第1期);1-4 *

Also Published As

Publication number Publication date
JP2019516726A (ja) 2019-06-20
US10456376B2 (en) 2019-10-29
EP3459541B1 (en) 2021-09-15
KR20170131240A (ko) 2017-11-29
ES2893456T3 (es) 2022-02-09
JP6986521B2 (ja) 2021-12-22
US20190216780A1 (en) 2019-07-18
CA3024278A1 (en) 2017-11-23
CN109310670A (zh) 2019-02-05
KR102421006B1 (ko) 2022-07-14
EP3459541A1 (en) 2019-03-27
WO2017200316A1 (ko) 2017-11-23
US20200009113A1 (en) 2020-01-09
EP3459541A4 (en) 2020-01-08

Similar Documents

Publication Publication Date Title
CN109310670B (zh) 氨基甲酸酯化合物用于预防性治疗头痛的用途
KR20050113163A (ko) 모다피닐의 제약 제제
BRPI0618239A2 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusico
CN109475529B (zh) 氨基甲酸酯化合物用于预防或治疗纤维肌痛或与纤维肌痛相关的功能综合征的用途
MD3347002T2 (ro) Tratamentul bolii Alzheimer într-o populație specifică de pacienți
KR20010032009A (ko) 수면성 무호흡의 치료에 미타자핀을 사용하는 방법
JP7417595B2 (ja) てんかん重積状態の予防、軽減又は治療のためのカルバメート化合物の使用
PT1628652E (pt) Combinação do modafinil analéptico e um antidepressivo para o tratamento da depressão
CN114288289A (zh) 具有镇痛和/或止痒功能的药物组合物及其应用
EP3556366A1 (en) Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
BR112012020169A2 (pt) utilização da agomelatina para a obtenção de medicamentos destinados ao tratamento do transtorno obsessivo compulsivo (toc).
HK40003858A (en) Use of carbamate compound in order to preventatively treat headaches
HK40003858B (en) Use of carbamate compound in order to preventatively treat headaches
CA2684171C (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-4-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
EP3556363B1 (en) Use of carbamate compound for prevention, alleviation or treatment of pruritus
JP2011088919A (ja) アゴメラチンとノルアドレナリン再取り込み阻害剤との新たな組み合わせ、及びそれを含有している医薬組成物
JP6465592B2 (ja) 涙液分泌促進組成物
HK40069667A (en) Pharmaceutical composition with analgesic and/or antipruritic function and uses thereof
JP4222614B2 (ja) 神経因性疼痛治療剤
HK40015213A (en) Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
JPH0256426A (ja) 虚血性脳障害処置剤
BR112021012491A2 (pt) Combinações antineurodegenerativas de domperidona e uso
MX2007014396A (es) Composicion farmaceutica que comprende 1-(3-clorofenil)-3- alquilpiperazina para el tratamiento de trastorno alimenticio.

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40003858

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant